CDB-2914: Anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits

Human Reproduction

Volumn 15, Issue 4, 2000, Pages 822-829

  Hild, Sheri Ann ^a   Jerry, R Reel ^a   Loren, H Hoffman ^b   Richard, P Blye ^c  

^a BIOQUAL INC   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Agonist; Antagonist; Anti fertility; Glucocorticoid; Progestin

Indexed keywords

17ALPHA ACETOXY 11BETA (4 DIMETHYLAMINOPHENYL) 19 NORPREGNA 4,9 DIENE 3,20 DIONE; ANTIGESTAGEN; ESTRADIOL; GESTAGEN; GLUCOCORTICOID ANTAGONIST; HAPTOGLOBIN; LEVONORGESTREL; MIFEPRISTONE; POSTCOITUS CONTRACEPTIVE AGENT; PROGESTERONE; UNCLASSIFIED DRUG;

AGONIST; ANIMAL MODEL; ARTICLE; CONTRACEPTION; DRUG ANTAGONISM; FEMALE FERTILITY; IN VIVO STUDY; NONHUMAN; RABBIT; RAT; TREATMENT OUTCOME;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0034124343     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.4.822     Document Type: Article

References (49)

1. Baulieu, E.E. (1991) RU486, an antisteroid molecule: cellular mechanism and clinical uses. In Hardy, M.A. and Kinne, R.K.H. (eds) Biology and medicine into the 21st century, issues blamed. Karger, Basel, pp. 127-157.
2. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
3. Busso, N., Collait, M., Vassalli, J-D. and Belin, D. (1987) Antagonist effect of RU486 on transcription of glucocorticoid-regulated genes. Exp. Cell Res., 173, 425-430.
4. Cadepond, R, Ulmann, A. and Baulieu, E-E. (1997) RU486 (MIFEPRISTONE): mechanisms of action and clinical uses. Ann. Rev. Med.. 48, 129-156.
5. Chang, C.C., Wang, W-C. and Bardin, C.W. (1993) Termination of early pregnancy in the rat, rabbit, and hamster with RU 486 and anordrin. Contraception, 47, 597-608.
6. Chen, S.H., Dharmarajan, A.M., Wallach, E.E. and Mastroyannis, C. (1995) RU486 inhibits ovulation, fertilization and early embryonic development in rabbits: m vivo and m vitro studies. Fertil. Steril., 64, 627-633.
7. Cook, C.E., Wani, M.C., Lee, Y-W. et al. (1992) Reversal of activity profile in analogs of the antiprogestin RU486: Effect of 16 -substituent on progestational (agonist) activity. Life Sei., 52, 155-162.
8. Cook, C.E., Lee, Y-W, Wani, M.C. et al. (1994) Effects of D-ring substituents on antiprogestational (antagonist) and progestational (agonist) activity of 11 -aryl steroids. Hum. Reprod., 9, 32-39.
9. Elton, R.L. and Edgren, R.A. (1958) Biological actions of 17α-(2-methallyl)19-nortestosterone, an orally active progestational agent. Endocrinology, 63, 464.
10. Gagne, D., Pons, M. and Philibert, D. (1985) RU38486: A potent antiglucocorticoid m vitro and in vivo. J. Steroid. Biochem., 23, 247-251.
11. Gagne, D., Pons, M. and Crates de Faulet, A. (1986) Analysis of the relation between receptor binding affinity and antagonist efficacy of antiglucocorticoids. J. Steroid. Biochem., 25, 315-322.
12. Gemzell-Danielsson, K., Svalander, P., Swahn, M-L. et al. (1994) Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase. Hum. Reprod., 9, 2398-2404.
13. Gemzell-Danielsson, K., Westlund, P., Johannisson, E. et al. (1996) Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum. Reprod., 11, 256-264.
14. Gemzell-Danielsson, K., Swahn, M-L., Westlund, P. et al. (1997) Effect of low daily doses of mifepristone on ovarian function and endometrial development. Hum. Reprod., 12, 124-131.
15. Ghosh, D., Sengupta, J. and Hendrickx, A.G. (1996) Effect of a single-dose, early luteal phase administration of mifepristone (RU486) on implantation stage endometrium in the rhesus monkey. Hum. Reprod., 11, 2026-2035.
16. Gravanis, A., Schaison, G., George, M. et at. (1985) Endometrial and pituitary responses to the steroidal antiprogestin RU486 in postmenopausal women. J. Clin. Endocrinol. Aletab., 60, 156-163.
17. Greb, R.R., Kiesel, L., Selbmann, A.K. et al. (1999) Disparate actions of mifepristone (RU 486) on glands and stroma in primate endometrium. Hum. Reprod., 14, 198-206.
18. Greene, K.E., Kettel, L.M. and Yen, S.S.C. (1992) Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of the luteal phase of the menstrual cycle: a contraceptive potential. Fertil. Steril, 58, 338-343.
19. Gronemeyer, H., Benhamou, B., Berry, M. et al. (1992) Mechanisms of antihormone action. J. Steroid. Biochem. Molec. Biol, 41, 217-221.
20. Hackenberg, R., Hannig, K., Beck, S. et al. (1996) Androgen-like and antiandrogen-like effects of antiprogestins in human mammary cancer cells. Eur. J. Cancer, 32A, 696-701.
21. Heikinheimo, O., Kontula, K., Croxatto, H. et al. (1987) Plasma concentrations and receptor binding of RU486 and its metabolites in humans. J. Steroid. Biochem., 26, 279-284.
22. Hodgen, G.D., Van Uem, J.F.H.M., Chilik, C.F. et al. (1994) Non-competitive anti-oestrogenic activity of progesterone antagonists in primate models. Hum. Reprod., 9, 77-81.
23. Huffman, L.H., Winfrey, V.P., Blaeuer, G.L. and Oison, G.E. (1996) A haptoglobin-like glycoprotein is produced by implantation-stage rabbit endometrium. Biol. Reprod., 55, 176-184.
24. Kanayama, K., Sankai, T., Nariai, K. and Endo, T. (1996) Blockade of ovulation in rabbits by RU-486, a competitive progesterone antagonist. J. Vet. Med. Sei., 58, 275-276.
25. Kloosterboer, H.J., Deckers, G.H.J., Van Der Heuvel, M.J. and Loozen, H.JJ. (1988) Screening of anti-progestagens by receptor studies and bioassays. J. Steroid. Biochem., 31, 567-571.
26. Koering, M.J., Healy, D.L. and Hodgen, G.D. (1986) Morphologic response of endometrium to a progesterone receptor antagonist, RU486, in monkeys. Fertil. Steril., 45, 280-287.
27. Kupfer, D. and Partridge, R. (1970) Corticoid mediated increase in tyrosinea-ketoglutarate transaminase in the rat: a sensitive glucocorticoid assay. Endocrinology, 87, 1198-1204.
28. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
29. Lamer, J.M., Hild-Petito, S., Reel, J.R. and Blye, R.P. (1996) Pharmacokinetics of a new antiprogestin, CDB-2914, [11 -(4-N,N-dimethylaminophenyl)]-17-acetoxy-19-norpregna-4,9-diene-3,20-dione, in the intact female rhesus monkey. Tlie Endocrine Society Abstracts P2-691, 577.
30. McPhail, M.K. (1934) The assay of progestin. J. Physiol. Land., 83, 145-156.
31. Meyer, M-E., Pomon, A., Ji, J. et al (1990) Agonistic and antagonistic activities of RU 486 on the functions of the human progesterone receptor. EMBO J., 9, 3923-3932.
32. National Research Council (1996) Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources Commission on Life Sciences, National Academy Press, Washington DC.
33. Neef, G., Beier, S., Elger, W. et al. (1984) New steroids with antiprogestational and antiglucocorticoid activities. Steroids, 44, 349-372.
34. Olson, G.E., Winfrey, V.P., Matrisian, P.E. et al. (1997) Specific expression of haptoglobin mRNA in implantation-stage rabbit uterine epithelium. J. Endocrinol., 152, 69-80.
35. Passaro, M., Piquion, J., Müllen, N. et al. (1997) Safety and luteal phase effects of the antiprogestin CDB-2914 in normally cycling women. The Endocrine Society Abstracts PI-370, 227.
36. Piaggio, G., von Hertzen, H., Grimes, D. and Van Look, PR A. (1999) Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Lancet, 353, 697-702.
37. Rauch, M., Loosfelt, H., Philibert, D. and Milgrom, E. (1985) Mechanism of action of an antiprogesterone, RU486, in the rabbit endometrium: effects of RU486 on the progesterone receptor and on expression of the uteroglobin gene. Eur. J. Biochem., 148, 213-218.
38. Reel, J.R., Hild-Petito, S. and Blye, R.P. (1998) Anti-ovulatory and postcoital antifertility activity of the antiprogestin CDB-2914 when administered as a single, multiple, or continuous dose to rats. Contraception, 58, 129-136.
39. Ringler, I., West, K., Dulin, W.E. and Boland E. (1964) Biological potencies of chemically modified adrenocorticosteroids in rats and man. Metabolism, 13, 37-44.
40. Slayden, O.D. and Brenner, R.M. (1994) RU486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaco mulatto). J. Clin. Endocrinol. Metab.. 78, 440-448.
41. Slayden, O.D., Zelinski-Wooton, M.B., Chwalisz, K. et al. (1998) Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: Morphometric assessment of the uterus and oviduct. Hum. Reprod., 13, 269-277.
42. Spitz, I.M. and Bardin, C.W. (1993) Clinical pharmacology of RU486 - an antiprogestin and antiglucocorticoid. Contraception, 48, 403-444.
43. Spitz, I.M., Croxatto, H.B. and Robbins, A. (1996) Antiprogestins: mechanism of action and contraceptive potential. Ann. Rev. Pharmacol. Toxicol., 36, 47-81.
44. Tarantal, A.F., Hendrickx, A.G, Matlin, S.A. et al. (1996) Effects of two antiprogestins on early pregnancy in the long-tailed macaque (Macaco fascicularis). Contraception, 54, 107-115.
45. Teutsch, G. and Philibert, D. (1994) History and perspectives of antiprogestins from the chemist's point of view. Hum. Reprod., 9, 12-31.
46. Wagner, B.L., Pollio, G., Leonhardt, S. et al. (1996) 16 -substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity. Proc. Natl Acad. Sei. USA, 93, 8739-8744.
47. Wagner, B.L., Pollio, G., Giangrande, P. et al. (1999) The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: Implications for the development of dissociated antiprogestins. Endocrinology, 140, 1449-1458.
48. Wolf, J.P., Ulmann, A., Hsiu, J.G. et al. (1989) Noncompetitive antiestrogenic effect of RU486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil. Steril., 52, 1055-1060.
49. Zelinski-Wooton, M.B., Slayden, O.D., Chwalisz, K. et al. (1998) Chronic treatment of female rhesus monkeys with low doses of the antiprogestin ZK 137 316: Establishment of a regimen that permits normal menstrual cyclicity. Hum. Reprod., 13, 259-267.